1. Mizani, S., Keshavarz, A., Vazifeh Shiran, N., Bashash, D., & Allahbakhshian, F. M. (2022). Expression changes of SIRT1 and FOXO3a significantly correlate with oxidative stress resistance genes in AML patients. Indian Journal of Hematology and Blood Transfusion, 39, 1–10.
2. Kargar-Sichani, Y., Mohammadi, M. H., Amiri, V., Barzegar, M., Keshavarz, A., Bashash, D., & Farsani, M. A. (2023). Effect of acute myeloid leukemia-derived extracellular vesicles on bone marrow mesenchymal stromal cells: expression of poor prognosis genes. Archives of Medical Research, 54(2), 95–104.
3. Wu, X., Li, S., Chen, D., Zheng, G., Zhang, Z., Li, Z., Sun, X., Zhao, Q., & Xu, J. (2022). An inflammatory response-related gene signature associated with immune status and prognosis of acute myeloid leukemia. American Journal of Translational Research, 14(7), 4898.
4. Pourrajab, F., Zare-Khormizi, M. R., Hashemi, A. S., & Hekmatimoghaddam, S. (2020). Genetic characterization and risk stratification of acute myeloid leukemia. Cancer Management and Research, 12, 2231.
5. Awada, H., Mustafa Ali, M. K., Thapa, B., Awada, H., Seymour, L., Liu, L., Gurnari, C., Kishtagari, A., Wang, E., & Baer, M. R. (2022). A focus on intermediate-risk acute myeloid leukemia: sub-classification updates and therapeutic challenges. Cancers, 14(17), 4166.